3Rummel A,Mahrhold S,Bigaike H,et al. The Hcc domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction[J].Mol Mierobiol,2004,51(3) :631-643.
4Breidenbach MA, Brunger AT. New insights into clostridial neurotoxin SNARE interaetions[J]. Trends Mol Med, 2006,11 (8) :376-381.
6Arnon SS,Schechter R, Inglesbt TV,et al. Botulinum toxin as a biological weapon : medical and public health management[J]. JAMA,2001,285(8) : 1059-1070.
1Whitby M,Sreet AC,Ruff TA,et al.Biological agents as weapons 1:amalpox and botulism[J].Med J Aust,2002,176:431
2Shi YL,Wang ZF.Cure of experimental botulism and antivotulismic effect of toosendanin[J].Acta Pharmacol Sin,2004,25:839
3Breidenbach MA,Brunger AT.New insights into clostridial neurotoxin-SNARE interactions[J].Trends Mol Med,2006,11:376
4Rummel A,Mahrhold S,Bigaike H,et al.The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction[J].Mol Microbiol,2004,51:631
5Lacy DB,Tepp W,Cohen AC,et al.Crystal structure of botulinum neurotoxintype A and implications for toxicity[J].Nat Struct Biol,1998,5:898
6Swaminathan S,Eswaramoorthy S.Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B[J].Nat Struct Biol,2000,7:693
